# Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment

> **NCT01100125** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 140 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** insulin dose increase

## Key facts

- **NCT ID:** NCT01100125
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2013-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100125, "Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01100125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*